Isomer-specific chromatographic profiling yields highly sensitive and specific potential N-glycan biomarkers for epithelial ovarian cancer.
about
In 2014, can we do better than CA125 in the early detection of ovarian cancer?Clinical Glycomics Employing Graphitized Carbon Liquid Chromatography-Mass SpectrometryAdvances in coupling microfluidic chips to mass spectrometry.The serum glycome to discriminate between early-stage epithelial ovarian cancer and benign ovarian diseases.Polysialylated N-glycans identified in human serum through combined developments in sample preparation, separations, and electrospray ionization-mass spectrometry.Evaluation of glycomic profiling as a diagnostic biomarker for epithelial ovarian cancer.Analytical platform for glycomic characterization of recombinant erythropoietin biotherapeutics and biosimilars by MS.Isomer-specific LC/MS and LC/MS/MS profiling of the mouse serum N-glycome revealing a number of novel sialylated N-glycansOligosaccharide analysis by mass spectrometry: a review of recent developmentsSerum glycan signatures of gastric cancer.Identification of 34 N-glycan isomers in human serum by capillary electrophoresis coupled with laser-induced fluorescence allows improving glycan biomarker discovery.Characteristic Changes in Cell Surface Glycosylation Accompany Intestinal Epithelial Cell (IEC) Differentiation: High Mannose Structures Dominate the Cell Surface Glycome of Undifferentiated Enterocytes.Differential N-Glycosylation Patterns in Lung Adenocarcinoma TissueMicrofluidic Chip-LC/MS-based Glycomic Analysis Revealed Distinct N-glycan Profile of Rat Serum.Relative Quantification and Higher-Order Modeling of the Plasma Glycan Cancer Burden Ratio in Ovarian Cancer Case-Control Samples.In-depth characterization of N-linked oligosaccharides using fluoride-mediated negative ion microfluidic chip LC-MSDifferentiation of cancer cell origin and molecular subtype by plasma membrane N-glycan profiling.Characterization of O-acetylation in sialoglycans by MALDI-MS using a combination of methylamidation and permethylation.Recent developments in microfluidic chip-based separation devices coupled to MS for bioanalysis.Microfluidic chip-based liquid chromatography coupled to mass spectrometry for determination of small molecules in bioanalytical applications: an update.Tissue glycomics distinguish tumour sites in women with advanced serous adenocarcinoma.Mass spectrometric profiling reveals association of N-glycan patterns with epithelial ovarian cancer progression.Integration of microfluidic LC with HRMS for the analysis of analytes in biofluids: past, present and future.Fragmentation and ion mobility properties of negative ions from N-linked carbohydrates: Part 7. Reduced glycans.Salmonella Typhimurium Enzymatically Landscapes the Host Intestinal Epithelial Cell (IEC) Surface Glycome to Increase Invasion.Designation of fingerprint glycopeptides for targeted glycoproteomic analysis of serum haptoglobin: insights into gastric cancer biomarker discovery.Microphysiologic systems in female reproductive biology.Changes in cellular glycosylation of leukemia cells upon treatment with acridone derivatives yield insight into drug action.Various sulfated carbohydrate tumor marker candidates identified by focused glycomic analyses.Clinical glycomics for the diagnosis of congenital disorders of glycosylation.The Alzheimer's Disease-Associated R47H Variant of TREM2 Has an Altered Glycosylation Pattern and Protein Stability
P2860
Q26825152-91A88FF1-9962-42F2-8172-39553ACE02F1Q27024150-B561994E-4304-466A-BBEA-A89607E2A329Q31147615-D178D2C4-6507-4EB6-BCBB-0DFB11C2D83EQ34092935-BD8E9122-B004-4304-A200-84D741AAF0F1Q34120306-B523A085-78C5-4899-8E09-98A5D1D50290Q34503577-FC6A1EAD-C02C-4FBB-9B7A-2AD569E2347BQ34593205-1A3D0D6A-D131-4BBC-B64C-0F1EA1AAEFA2Q34638339-FBEC294C-67FE-468F-98BB-A2FBC8BCD3A8Q35061645-002D676E-D3B7-47B3-B165-D4F6401533F5Q35064779-DE639C09-2A0B-41E6-AE71-9636B0FFB8A0Q35262822-9DBDED6D-B13D-4E91-B684-0B31C6B17383Q36263012-7A90ABB0-B5BB-478F-A6A9-2AA0D1BD403BQ36278033-A1F61D6D-A0BA-4E1F-ADC4-CA49E3734C34Q36293747-6093238B-5C5A-4688-BF0B-2A32F4A0EF79Q36490028-044531FC-5E10-4637-9B10-507B5274BA26Q36704033-26D6D66A-244A-4ED4-AAA1-DE3F07533ECDQ37624209-C3BA8582-4B5C-4655-95F4-4D6C3EDF3832Q37741292-A238D0F9-6086-4DEE-8512-A53103ADD207Q38153800-C5CFC952-F5BE-4A85-8B2B-79C710A37526Q38156035-0ED1D06C-4A45-4A56-8C2F-2E8E5AFC51B4Q38602517-2955F4E0-97AC-4B00-AF1D-3056C59415A3Q38697958-E4AD66CD-AC2F-46E3-A1BB-3F0E1BF9ABB1Q38991660-B9990549-9BAC-422E-ADFC-DA70B3075475Q40026665-6F5AEFEA-1A88-4CA7-A4EA-C7C8588A3911Q40501498-B05AA950-C3BC-473F-9B49-A62FCC792B77Q47213195-E175E3A7-BC40-4870-A133-86B70406DFB7Q47600086-30E0D515-B057-4B08-A3DA-6CE0F4BCD8E0Q51417363-E566ADAD-97C2-4087-9E04-F0D2361D5AEEQ53609090-A38F3B3D-89D3-4A0A-A8FE-36B57E0F2026Q54959588-2A58F011-DB45-48FC-ADF1-C6FCA211FD07Q58552894-E4800B20-79FF-4E64-9C60-B9464172954D
P2860
Isomer-specific chromatographic profiling yields highly sensitive and specific potential N-glycan biomarkers for epithelial ovarian cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Isomer-specific chromatographi ...... for epithelial ovarian cancer.
@en
Isomer-specific chromatographi ...... for epithelial ovarian cancer.
@nl
type
label
Isomer-specific chromatographi ...... for epithelial ovarian cancer.
@en
Isomer-specific chromatographi ...... for epithelial ovarian cancer.
@nl
prefLabel
Isomer-specific chromatographi ...... for epithelial ovarian cancer.
@en
Isomer-specific chromatographi ...... for epithelial ovarian cancer.
@nl
P2093
P2860
P1476
Isomer-specific chromatographi ...... for epithelial ovarian cancer
@en
P2093
Carlito B Lebrilla
Cynthia C Williams
Gary S Leiserowitz
Grace S Ro
Lauren M Dimapasoc
Serenus Hua
Sureyya Ozcan
Suzanne Miyamoto
P2860
P356
10.1016/J.CHROMA.2012.12.079
P407
P50
P577
2013-01-11T00:00:00Z